Citadel Advisors’s UBS AG 2XMTHLY LEV LG EXCH TRD ACCESS SEC E-TRACS ALERIAN MLPL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
Sell
-9,470
Closed -$232K 9624
2015
Q3
$232K Buy
+9,470
New +$332K ﹤0.01% 5945

Other funds holding MLPL

Citadel Advisors's MLPL Position: Q4 2015 in Review

Citadel Advisors sold out of UBS AG 2XMTHLY LEV LG EXCH TRD ACCESS SEC E-TRACS ALERIAN (MLPL) in Q4 2015, closing a stake of 9,470 shares — an estimated $232K sold.

Citadel Advisors first reported a position in MLPL in Q3 2015 and held it in 1 quarter. The position peaked at $232K in Q3 2015. 18 funds tracked by Wall St. Rank hold MLPL as of Q4 2015.

  • Citadel Advisors reported no remaining UBS AG 2XMTHLY LEV LG EXCH TRD ACCESS SEC E-TRACS ALERIAN position as of Q4 2015 after selling out during the quarter.
  • Citadel Advisors sold 9,470 UBS AG 2XMTHLY LEV LG EXCH TRD ACCESS SEC E-TRACS ALERIAN shares in Q4 2015, an estimated $232K.
  • Citadel Advisors first reported a position in UBS AG 2XMTHLY LEV LG EXCH TRD ACCESS SEC E-TRACS ALERIAN in Q3 2015 and held it in 1 quarter.
  • Citadel Advisors's UBS AG 2XMTHLY LEV LG EXCH TRD ACCESS SEC E-TRACS ALERIAN position peaked at $232K in Q3 2015.
  • 18 funds tracked by Wall St. Rank held UBS AG 2XMTHLY LEV LG EXCH TRD ACCESS SEC E-TRACS ALERIAN as of Q4 2015.

Based on Citadel Advisors's 13F filing for Q4 2015, filed 12 Feb 2016.